Virbac SA (EPA:VIRP)
France · Delayed Price · Currency is EUR 353.50
-4.00 (-1.12%)
Jan 2, 2026, 5:35 PM CET
Virbac Employees
Virbac had 6,365 employees as of December 31, 2024. The number of employees increased by 906 or 16.60% compared to the previous year.
Employees
6,365
Change (1Y)
906
Growth (1Y)
16.60%
Revenue / Employee
€225,094
Profits / Employee
€20,900
Market Cap
3.00B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6,365 | 906 | 16.60% |
| Dec 31, 2023 | 5,459 | 73 | 1.36% |
| Dec 31, 2022 | 5,386 | 266 | 5.20% |
| Dec 31, 2021 | 5,120 | 213 | 4.34% |
| Dec 31, 2020 | 4,907 | 10 | 0.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 153,498 |
| emeis Société anonyme | 83,494 |
| Sanofi | 82,878 |
| Eurofins Scientific SE | 62,696 |
| Clariane SE | 61,798 |
| Ramsay Générale de Santé | 40,494 |
| bioMérieux | 14,754 |
| Sartorius Stedim Biotech | 9,901 |
Virbac News
- 15 days ago - Virbac (VRBCF) Acquires Feline Hyperthyroidism Treatment for £100M - GuruFocus
- 15 days ago - Virbac expands pet health portfolio with £100M acquisition of feline hyperthyroidism drug from Norbrook - Seeking Alpha
- 25 days ago - Virbac : Declaration of the number of shares and voting rights 11/2025 - GlobeNewsWire
- 2 months ago - VIRBAC Announces Third Quarter 2025 Sales - GlobeNewsWire
- 3 months ago - Virbac SA 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Virbac SA (VRBCF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Virbac: 2025 Half-year results - GlobeNewsWire
- 4 months ago - Virbac : Public release of the Half-Year Financial Report at 30 June 2025. - GlobeNewsWire